Cargando…
Hematopoietic cell kinase (HCK) as a therapeutic target in immune and cancer cells
The hematopoietic cell kinase (HCK) is a member of the SRC family of cytoplasmic tyrosine kinases (SFKs), and is expressed in cells of the myeloid and B-lymphocyte cell lineages. Excessive HCK activation is associated with several types of leukemia and enhances cell proliferation and survival by phy...
Autores principales: | Poh, Ashleigh R., O'Donoghue, Robert J.J., Ernst, Matthias |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4599235/ https://www.ncbi.nlm.nih.gov/pubmed/26087188 |
Ejemplares similares
-
Targeting H(i)ck education for cancer therapy?
por: Ernst, Matthias, et al.
Publicado: (2017) -
Therapeutic inhibition of the SRC-kinase HCK facilitates T cell tumor infiltration and improves response to immunotherapy
por: Poh, Ashleigh R., et al.
Publicado: (2022) -
Selective targeting of the inactive state of hematopoietic cell kinase (Hck) with a stable curcumin derivative
por: Chakraborty, Manas Pratim, et al.
Publicado: (2021) -
Identification of the SRC-family tyrosine kinase HCK as a therapeutic target in mantle cell lymphoma
por: Lantermans, Hildo C., et al.
Publicado: (2020) -
The SH3 regulatory domain of the hematopoietic cell kinase Hck binds ELMO via its polyproline motif
por: Awad, Rida, et al.
Publicado: (2015)